黑色素度激素:抗抑郁药治疗的有希望的目标
Lingchang Shi1, Ying He2, Yujun Lian3
1School of Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
Pharmacology, biochemistry, and behavior
|March 13, 2025
概括
黑色素缩激素 (MCH) 信号传递是新的抑郁症治疗的有希望的目标. 在早期研究中,MCH受体1 (MCHR1) 抗剂在早期研究中显示出快速的抗抑郁作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 内分泌学 在内分泌学.
背景情况:
- 抑郁症是一种复杂的神经精神疾病,对全球健康产生重大影响.
- 目前的抑郁症治疗方法在有效性和副作用方面存在局限性.
- 神经系统,特别是MCH信号传递,越来越多地被认为是它们在情绪调节中的作用.
研究的目的:
- 系统地审查MCH信号与抑郁症之间的机制性相互作用.
- 探索MCH在下丘脑-垂体-上腺 (HPA) 轴,神经递质系统,突触可塑性和睡眠-觉醒调节中的作用.
- 评估MCH受体1 (MCHR1) 对抗剂对抑郁症的治疗潜力.
主要方法:
- 对调查MCH信号和抑郁症的研究进行系统文献综述.
- 对MCHR1抗剂的临床前数据的分析.
- 检查MCH对与抑郁相关的神经生物学机制的影响.
主要成果:
- 越来越多的证据表明,MCH信号参与了抑郁症的病理生理学.
- 在临床前模型中,MCHR1对抗剂在临床前模型中显示出快速开始的抗抑郁药疗效.
- 在HPA轴,神经传递,可塑性和睡眠中MCH系统的作用需要进一步研究.
结论:
- 对于抗抑郁药的开发,MCH信号传递是一个有前途的新目标.
- MCHR1抗剂提供了一个潜在的治疗策略,具有快速的疗效.
- 需要进一步的研究,以充分阐明MCH系统的抗抑郁机制.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
174
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
174
01:25Antidepressant Drugs: Overview
344
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
344
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
266
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
266
01:19Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
01:18Depression: Overview
205
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
205
01:21G-protein Coupled Receptors
114.1K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
114.1K